drugset / Trial / NCT02862977

Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine and Caffeine in Osteomuscular Treatment

NCT02862977

Phase 3 Completed 414 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of an association with one anti-inflammatory and one muscle relaxant plus caffeine compared to one anti-inflammatory plus caffeine in the treatment of osteomuscular pain in adults.

Timeline

Start
2017-11-10
Primary completion
2019-06-05
Completion
2019-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule Oral
Comparator Caffeine Small molecule Oral
Comparator cyclobenzaprine Small molecule Oral